4//SEC Filing
MORSE DANIEL E. 4
Accession 0001144204-18-053713
CIK 0001540159other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 9:50 PM ET
Size
4.9 KB
Accession
0001144204-18-053713
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Sale
Common Shares, without par value
2018-10-12$1.31/sh−7,047$9,260→ 20,741 total
Footnotes (1)
- [F1]The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeother
Related Parties
1- filerCIK 0001621331
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 9:50 PM ET
- Size
- 4.9 KB